Ian Woodcock

5PUBLICATIONS
12CO-AUTHORS
Rehabilitation engineeringInfant and child healthMolecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Jennifer M Kwon, Francina Munell, Laure Le Goff

|Dec 08, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Jennifer M Kwon, Francina Munell, Laure Le Goff

|May 14, 2025
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double-blind placebo-controlled crossover trial.

Ian R Woodcock, Katy de Valle, Anita Cairns

|Jan 25, 2024
A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice.

Ian R Woodcock, George Tachas, Nuket Desem

|Mar 25, 2022
A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy-Not Just a Muscle Defect.

Chantal A Coles, Ian Woodcock, Daniel G Pellicci

Pageof 1

Frequent Collaborators

2 joint publications

Gemma Williams

2 joint publications

Jennifer M Kwon

2 joint publications

Tamaki Kato

2 joint publications

Liesbeth De Waele